XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Deferred Compensation Equity
Accumulated Other Comprehensive Income (loss)
Retained Earnings
Shares in Treasury
Increase (Decrease) in Shareholders' Equity              
Adoption of accounting standards | Adjustments for New Accounting Pronouncement $ 6.5       $ (6.5) $ 13.0  
Balance at the beginning of the period at Dec. 31, 2017 2,528.3 $ 78.7 $ 353.7 $ 10.4 (85.7) 2,820.8 $ (649.6)
Balance (in shares) at Dec. 31, 2017   61,800,000         16,600,000
Increase (Decrease) in Shareholders' Equity              
Net income 423.3         423.3  
Other comprehensive income (loss), net of tax (10.7)       (10.7)    
Cash dividends (45.6)         (45.6)  
Repurchases of common stock (240.6)           $ (240.6)
Repurchases of common stock (in shares)   (2,200,000)         2,200,000
Issuances and deferrals. net for stock based compensation (1) [1] 11.1   12.1 (2.6)     $ 1.6
Issuances and deferrals, net for stock based compensation (in shares) [1]   200,000         (200,000)
Balance at the end of the period at Jun. 30, 2018 2,672.3 $ 78.7 365.8 7.8 (102.9) 3,211.5 $ (888.6)
Balance (in shares) at Jun. 30, 2018   59,800,000         18,600,000
Balance at the beginning of the period at Mar. 31, 2018 2,720.8 $ 78.7 357.6 11.1 (68.9) 3,120.3 $ (778.0)
Balance (in shares) at Mar. 31, 2018   60,700,000         17,700,000
Increase (Decrease) in Shareholders' Equity              
Net income 113.7         113.7  
Other comprehensive income (loss), net of tax (34.0)       (34.0)    
Cash dividends (22.5)         (22.5)  
Repurchases of common stock (111.3)           $ (111.3)
Repurchases of common stock (in shares)   (1,000,000.0)         1,000,000.0
Issuances and deferrals. net for stock based compensation (1) 5.6   8.2 (3.3)     $ 0.7
Issuances and deferrals, net for stock based compensation (in shares)   100,000         (100,000)
Balance at the end of the period at Jun. 30, 2018 2,672.3 $ 78.7 365.8 7.8 (102.9) 3,211.5 $ (888.6)
Balance (in shares) at Jun. 30, 2018   59,800,000         18,600,000
Balance at the beginning of the period at Dec. 31, 2018 $ 2,597.4 $ 78.7 383.8 $ 8.0 (122.1) 3,351.4 $ (1,102.4)
Balance (in shares) at Dec. 31, 2018 57,957,912 57,900,000         20,500,000
Increase (Decrease) in Shareholders' Equity              
Net income $ 232.3         232.3  
Other comprehensive income (loss), net of tax 1.6       1.6    
Cash dividends (46.2)         (46.2)  
Repurchases of common stock (224.9)           $ (224.9)
Repurchases of common stock (in shares)   (1,900,000)         1,900,000
Issuances and deferrals. net for stock based compensation (1) [1] 23.0   13.5       $ 14.5
Issuances and deferrals, net for stock based compensation (in shares) [1]   400,000   (5,000,000.0)     (400,000)
Balance at the end of the period at Jun. 30, 2019 $ 2,583.2 $ 78.7 397.3 $ 3.0 (120.5) 3,537.5 $ (1,312.8)
Balance (in shares) at Jun. 30, 2019 56,420,192 56,400,000         22,000,000.0
Balance at the beginning of the period at Mar. 31, 2019 $ 2,524.7 $ 78.7 390.1 7.8 (115.9) 3,407.5 $ (1,243.5)
Balance (in shares) at Mar. 31, 2019   56,800,000         21,600,000
Increase (Decrease) in Shareholders' Equity              
Net income 152.9         152.9  
Other comprehensive income (loss), net of tax (4.6)       (4.6)    
Cash dividends (22.9)         (22.9)  
Repurchases of common stock (75.0)           $ (75.0)
Repurchases of common stock (in shares)   (600,000)         600,000
Issuances and deferrals. net for stock based compensation (1) 8.1   7.2 (4.8)     $ 5.7
Issuances and deferrals, net for stock based compensation (in shares)   200,000         (200,000)
Balance at the end of the period at Jun. 30, 2019 $ 2,583.2 $ 78.7 $ 397.3 $ 3.0 $ (120.5) $ 3,537.5 $ (1,312.8)
Balance (in shares) at Jun. 30, 2019 56,420,192 56,400,000         22,000,000.0
[1] Issuances and deferrals, net for stock based compensation reflects share activity related to option exercises, restricted and performance shares vested and net issuances and deferrals associated with deferred compensation equity.